Tag: Hormones: Misc.
Gender-Affirming Hormone Therapy in Primary Care Tied to Reduced Depressive Symptoms
Findings seen for transgender, nonbinary, and gender-diverse adults
VA Ends Hormone Therapy for Newly Diagnosed Transgender Veterans
Venous Thromboembolism Risk Higher for Certain Hormonal Contraceptives
Standardized VTE rates highest for combined pills, especially those containing third-generation progestins
Gender-Affirming Medication Use Rare in U.S. Transgender Adolescents From 2018 to 2022
Findings seen among privately insured adolescents who identify as transgender and gender-diverse
Recommendations Updated on Diagnosis, Management of Premature/Primary Ovarian Insufficiency
Significant changes from previous guideline include recommendation that only FSH >25 IU required for POI diagnosis
Long-Term Sex Hormone Treatment in Transgender Care Tied to Changes in Body Composition
Longitudinal changes seen in regional fat and muscle composition and cardiometabolic biomarkers
Hormone-Modulating Therapy May Reduce Dementia Risk in Breast Cancer
Greatest reduction seen for women aged 65 to 74 years who self-identify as Black
Racial, Ethnic Differences Seen in Breast Cancer Treatment Declination
American Indian, Alaska Native, other; Asian or Pacific Islander; Black patients more likely to decline surgery
Neoadjuvant Chemohormonal Therapy Aids Locally Advanced Prostate Cancer
Significant benefits in terms of three-year biochemical progression-free survival seen for NCHT versus neoadjuvant hormonal therapy
Evidence Lacking for Gender Dysphoria Treatments for Teens
Two systematic reviews show inadequate evidence for use of treatment to suppress or lessen effect of puberty, hormone treatment
